Volume | 1,728,495 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 10.6001 | Mínimo Máximo |
|||||
Minimo del Dia | 10.39 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Adma Biologics Inc | ADMA | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
10.51 | 10.39 | 10.6001 | 10.47 | 10.58 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
16,474 | 1,728,495 | US$ 10.49 | US$ 18,127,809 | - | 3.06 - 10.855 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
17:55:49 | 10 | US$ 10.40 | USD |
Flujo de Opciones Adma Biologics (ADMA)
Información Financiera Adma Biologics Inc ADMA
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
2.39B | 228.22M | - | 258.22M | -28.24M | -0.12 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Adma Biologics Inc ADMA
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
04/6/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
17/5/2024 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 16:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
09/5/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 15:05 | GlobeNewswire Inc. | ADMA Biologics Announces First Quarter 2024 Financial.. |
09/5/2024 | 06:47 | IH Market News | U.S. Index Futures Dip, Bank of England Holds Interest Rates.. |
02/5/2024 | 06:00 | GlobeNewswire Inc. | ADMA Biologics to Report First Quarter 2024 Financial.. |
11/3/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
11/3/2024 | 11:19 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
11/3/2024 | 06:00 | GlobeNewswire Inc. | ADMA Biologics Announces FDA Approvals of Extended Room.. |
08/3/2024 | 20:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
05/3/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos ADMA
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 9.52 | 10.855 | 9.40 | 10.09 | 3,500,158 | 0.92 | 9.66% |
1 Month | 8.19 | 10.855 | 7.96 | 9.41 | 3,657,887 | 2.25 | 27.47% |
3 Months | 5.98 | 10.855 | 5.88 | 7.71 | 2,773,096 | 4.46 | 74.58% |
6 Months | 3.86 | 10.855 | 3.60 | 6.39 | 2,662,267 | 6.58 | 170.47% |
1 Year | 4.06 | 10.855 | 3.06 | 5.26 | 2,349,633 | 6.38 | 157.14% |
3 Years | 1.74 | 10.855 | 1.01 | 3.19 | 2,567,488 | 8.70 | 500.00% |
5 Years | 3.81 | 10.855 | 1.01 | 2.93 | 2,821,972 | 6.63 | 174.02% |